To hear about similar clinical trials, please enter your email below
Trial Title:
Atrial Fibrillation and Cancer: a Nationwide French Cohort Study
NCT ID:
NCT05563883
Condition:
Atrial Fibrillation
Cancer
Thromboembolism
Bleeding
Conditions: Official terms:
Atrial Fibrillation
Thromboembolism
Study type:
Observational
Overall status:
Active, not recruiting
Study design:
Time perspective:
Retrospective
Intervention:
Intervention type:
Other
Intervention name:
event occurence
Description:
occurence of an event of interest: (AF, cancer, thromboembolism, bleeding, mortality...
Summary:
Atrial fibrillation (AF) is a common complication associated with cancer but the risk of
AF according to the cancer localization and status as well as the risk of
thromboembolisms, bleedings and mortality are poorly known.
The objective of this study is to use a very large French nationwide cohort to adress
thèses questions.
Criteria for eligibility:
Study pop:
Patients hospitalized from january 2010 to december 2019 and having an available ICD-10
code discharge.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- adult hospitalized patients
- with an ICD-10 code discharge from january 2010 to december 2019 in the French
national hospital discharge database (PMSI Programme de Médicalisation des Systèmes
d'Information)
Exclusion Criteria:
- children
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Locations:
Facility:
Name:
Service de Cardiologie, Centre Hospitalier Universitaire Trousseau
Address:
City:
Tours
Zip:
37000
Country:
France
Start date:
September 22, 2022
Completion date:
January 2030
Lead sponsor:
Agency:
University Hospital, Caen
Agency class:
Other
Collaborator:
Agency:
University Hospital, Tours
Agency class:
Other
Source:
University Hospital, Caen
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05563883
